BRIANNA RICENBAW: Open Payments
NPI 1720862816 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,225 in 88 payments from 12 companies in 2025. Trend: 2023 $746 · 2024 $1,797 · 2025 $2,225
Food & beverage: $2,225
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $566 |
| AstraZeneca Pharmaceuticals LP | 16 | $507 |
| GlaxoSmithKline, LLC. | 29 | $323 |
| ABIOMED | 3 | $215 |
| Axsome Therapeutics, Inc. | 4 | $160 |
| Phathom Pharmaceuticals, Inc. | 4 | $147 |
| ABBVIE INC. | 1 | $120 |
| Lilly USA, LLC | 6 | $100 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
| Eisai Inc. | 1 | $28 |
Products named: Wegovy, TRELEGY ELLIPTA, AIRSUPRA, Ozempic, BREZTRI, Auvelity, VOQUEZNA, QULIPTA.
Industry payments across TX — which companies pay providers there.
